A selection of key IP facts and figures, as reported by IAM and other sources
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
@IAM_magazine RT @IAM_magazine: Addressing the patent situation around Gilead's remdesivir, a top Chinese patent office official signaled the need for st… Read more
@IAM_magazine Addressing the patent situation around Gilead's remdesivir, a top Chinese patent office official signaled the need… https://t.co/RdRFPUGE1v Read more
@IAM_magazine RT @ktMINEglobal: The countdown revealing the companies in this year's @IAM_magazine / ktMINE US Patent 100 continues by naming those in pl… Read more
@IAM_magazine It's part 2 of the IAM/@ktMINE US Patent 100 countdown of the world's largest US patent portfolios today - and we'r… https://t.co/nFZA7vYOOc Read more